AMR Action Fund — 2020 Investments
1 investments dated 2020 · listed companies and verified rows first · show all
Rgenta Therapeuticsrgentatx.cominJan 2020SEC filingmedium confidence
Rgenta Therapeutics develops small molecule RNA modulation therapies through a discovery platform, aiming to create treatment options for patients with unmet medical needs across multiple therapeutic areas.
AI & Machine LearningBiotechDeep TechCambridge, US
Judith Li(Director)Debasish Roychowdhury(Director)Travis Wager(Co-founder, President and CSO)Sun Linghao(Director)Hualin Simon Xi(Executive Officer, Director)Zhiping Weng(Co-founder)
Board seatMartin Heidecker· per SEC Form D · $38M raise · filed Mar 2021
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.